U.S. Senator Jeanne Shaheen (D-NH) helped introduce the bicameral Affordability is Access Act , which would require insurers to fully cover over-the-counter birth control without any fees or out-of-pocket costs, once it is Food and Drug Administration (FDA)-approved.
Will support legislation requiring insurers to fully cover over-the-counter birth control without fees or out-of-pocket costs once it is FDA-approved.
Occurrences
Evidence
unverified · Source version 87245 · locator unknown
U.S. Senator Jeanne Shaheen (D-NH) helped introduce the bicameral Affordability is Access Act, which would require insurers to fully cover over-the-counter birth control without any fees or out-of-pocket costs, once it is Food and Drug Administration (FDA)-approved.
verified · Source version 87248 · locator 1261
Mrs. Murray (for herself, Ms. Cortez Masto, Ms. Hirono, Ms. Baldwin, Mr. Bennet, Mr. Blumenthal, Mr. Booker, Ms. Cantwell, Ms. Duckworth, Mr. Fetterman, Mr. Gallego, Mrs. Gillibrand, Ms. Hassan, Mr. Heinrich, Mr. Hickenlooper, Mr. Kaine, Ms. Klobuchar, Mr. Markey, Mr. Merkley, Mr. Padilla, Mr. Reed, Ms. Rosen, Mr. Sanders, Mr. Schatz, Mr. Schiff, Mrs. Shaheen, Ms. Smith, Mr. Van Hollen, Mr. Warner, Ms. Warren, Mr. Whitehouse, and Mr. Wyden) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
unverified · Source version 87248 · locator unknown
Full Title To require group health plans and group or individual health insurance coverage to provide coverage for over-the-counter contraceptives.
verified · Source version 87250 · locator 1553
Today, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily oral contraceptive approved for use in the U.S. without a prescription.
Assessments
The verified commitment is to support/help advance the Affordability is Access Act requiring no-cost coverage of FDA-approved over-the-counter birth control, not necessarily to secure enactment of that coverage. Verified evidence shows Shaheen was listed among senators introducing the bill, and the bill was read twice and referred to committee. FDA approval of a nonprescription oral contraceptive is also verified, satisfying the condition referenced in the commitment. Because Shaheen materially participated in introducing/supporting the legislation during the same Senate term, the action commitment is delivered; enactment of the broader coverage outcome is not required for this occurrence.